Abstract
Background Previous studies have reported a positive relationship between higher hospital endovascular thrombectomy (EVT) volume and shorter procedures, higher revascularization rates, and improved functional outcomes. We investigated the association between hospital EVT volume and clinical outcomes using the National Inpatient Sample (NIS) database from 2016-2020.
Methods A cross-sectional analysis of the NIS examining the relationship of hospital EVT volume and outcomes was performed. All relevant clinical and demographic information was collected. The outcomes were favorable functional outcome (home without assistance), inpatient mortality, and intracerebral hemorrhage (ICH). Centers were classified as high-volume if they were in the top quintile of annual EVT volume. We performed univariate, multivariate, nearest neighbor matched analysis, and an exploratory annual case volume cutoff analysis.
Results There were 114,640 patients who underwent EVT included in the sample. Of these, 24,415 (21.3%) were in the high-volume group. High-volume centers had higher rates of favorable functional outcome in univariate (OR 1.20, p < 0.001), multivariate (aOR 1.19, p = 0.003), and matched analysis (OR 1.14, p = 0.028). Prior to matching, lower rates of inpatient mortality (OR 0.83, p < 0.001). However, in univariate and matched analysis there were no differences between high and low-volume centers. There were no differences in ICH across all analyses. Functional benefit was first noted at ≥ 50 EVTs, but centers performing ≥ 175 EVTs had substantially higher functional benefit (aOR 1.42, p = 0.002).
Conclusions Our analysis demonstrates increased hospital case volume is associated with a modest improvement in favorable functional outcomes in patients undergoing EVT for AIS. Attempts to identify procedural cut off values reveal likely improved functional outcomes beginning at 50 EVT per year, while this benefit seems to increase with increasing case volumes. These higher levels of case volumes do not lead to higher rates of inpatient mortality or ICH.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No sources of funding used to support this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study did no require IRB approval as the dataset was created and maintained by HCUP. We adhered to the HCUP data use agreement.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclosures: None
Funding: None
Data Availability
Data available to the public through the Healthcare Utilization Project.
